Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by Deutsche Bank AG

Deutsche Bank AG grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 21.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 647,022 shares of the company's stock after purchasing an additional 112,408 shares during the quarter. Deutsche Bank AG owned approximately 0.52% of Henry Schein worth $44,774,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Invesco Ltd. increased its holdings in shares of Henry Schein by 0.4% in the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after purchasing an additional 17,552 shares during the last quarter. FMR LLC increased its holdings in shares of Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after purchasing an additional 217,143 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after purchasing an additional 14,876 shares during the last quarter. Palestra Capital Management LLC acquired a new stake in shares of Henry Schein in the fourth quarter valued at approximately $182,988,000. Finally, Fiduciary Management Inc. WI boosted its holdings in Henry Schein by 7.2% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after purchasing an additional 167,990 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Performance

Shares of HSIC stock opened at $70.54 on Wednesday. The firm's 50 day moving average price is $67.52 and its 200-day moving average price is $71.45. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The firm has a market cap of $8.59 billion, a P/E ratio of 29.03, a P/E/G ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.10 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Piper Sandler cut their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Barrington Research cut their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Finally, StockNews.com cut Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $79.30.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.